HYPD

Hyperion DeFi, Inc. is engaged in building a long-term strategic treasury of Hyperliquid’s native token, HYPE. The Company is focused on providing simplified access to the Hyperliquid ecosystem. It is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. It has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.

Wall Street analysts forecast HYPD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Hyperion DeFi Inc revenue for the last quarter amounts to 302.51K USD, increased 18515.75 % YoY.

Hyperion DeFi Inc. EPS for the last quarter amounts to 0.20 USD, decreased -102.21 % YoY.

Hyperion DeFi Inc (HYPD) has 13 emplpoyees as of December 17 2025.

Today HYPD has the market capitalization of 25.17M USD.